EVMN

Evommune Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth 2/10
  • Value 0/10
Evommune sales and earnings growth
EVMN Growth
Fair
  • Revenue Y/Y 0.00%
  • EPS Y/Y 0.00%
  • FCF Y/Y 0.00%
Evommune gross and profit margin trends
EVMN Profitability
Low
  • Gross margin 100.00%
  • EPS margin -529.80%
  • ROIC 5Y 0.00%
Evommune net debt vs free cash flow
EVMN Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage 999.0

Evommune stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗